R-TRIBE 灰度分阶段通过机制:Canary + 渐进推广在中医辨证 OMOP dashboard 的 F4 兜底设计

Written by

in

Language

Evidence level: B

导言

R-TRIBE dashboard(P3-EXP-052)在前 4 轮已被定形为「OMOP CONCEPT_RELATIONSHIP 行级漂移实时监控 + Shiny 6 模块 + Kafka 流 + E_drift 边集哈希稳定性指标」的方法学基础设施。P3-EXP-053 红队测试已确认即便 DDC 三轴联合监控仍有攻击成功率(ASR)窗口,P3-EXP-054 CI/CD 4-Stage gate 已把红队测试嵌入每次 release 强制环节。然而这套机制的 F4 兜底条件——「CI/CD 全部 4 道 gate 通过、但运行中真实临床环境触发 F4 严重失败(用户投诉激增、临床误诊指控、证候误判跨中心聚集)」——目前还没有正式的回滚与渐进推广协议。

本轮课题 #175 把 IT 行业成熟的 canary deployment(灰度发布)范式迁移到 R-TRIBE 这类医学 dashboard 的 release 链路:当一个新的 R-TRIBE 镜像版本通过 P3-EXP-054 CI/CD 全部 gate、即将进入生产时,先在小比例中心(5% → 20% → 50% → 100%)逐阶段推广,并绑定 F4 触发的自动回滚条件与 SLA。这是 P3-EXP-054(CI/CD 自动化)的 H4 触发条件下的兜底机制。

本文聚焦三件事:(1) canary + 渐进推广在临床 AI 部署的现有最佳实践;(2) 把这一范式落到 R-TRIBE dashboard 的 4 阶段推广协议设计;(3) F4 触发条件(误诊指控 / 证候误判聚集 / 用户投诉)下的自动回滚与证据保全协议。

1. 现有最佳实践:canary + 灰度在临床 AI

放射科 RADAR 评估框架(PMID:38290193)把”AI 在放射科落地”分解为 5 阶段:算法开发→技术验证→shadow mode 评估→前瞻性实时评估→后市场监测。其核心论点是”shadow mode 必须独立成阶段、不能与前瞻性评估混在一起”——这与 P3-EXP-053 红队测试的 L1-L4 漂移检测分层一致。

临床 ML 部署监测综述(PMID:40482691)系统比较 17 种已部署临床 ML 模型的持续评估策略,提出”监测触发 + 重新校准 + 渐进回滚”的三件套。其结论是:当模型的 AUROC 在生产中下降超过 10% 时,应启动”灰度回滚”——先回退到上一稳定版本,同时保留日志供后续根因分析。

NICU 早产儿 BPD 预测 AI 的 shadow mode 评估(PMC 引用 2025)显示,shadow mode 阶段能识别出前瞻性试验中未发现的”夜间误报率”问题——这一发现正是在 P3-EXP-053 阶段 1 注入器校准中”对夜间边界样本”必须留有 L3 对抗伪装攻击者注入窗口的工程理由。

OHDSI 数据质量框架(PMID:34562705)规定 24 类标准数据质量检查必须在新版本 ETL 投产前在沙箱跑通——这是 R-TRIBE 镜像的 P3-EXP-054 阶段 1 dry-run 协议的方法学依据。

FDA PCCP(Predetermined Change Control Plan)指南(PMID:36851256)正式把”预定义变更控制”列为 AI/ML SaMD(Software as a Medical Device)的合规要求——”灰度 + 渐进推广 + 预定义回滚条件”是 PCCP 的核心三件套。

2. R-TRIBE Canary + 渐进推广协议

第一阶段(main 分支 → 5% 中心):
– 时间窗:7 天
– 中心选择:从三国(TKM/TCM/Kampo)OMOP 部署中各挑 1 个最低流量中心
– 监控指标:E_drift 边集哈希稳定性 ≥ 0.80、S_center 同步指数 ≥ 0.60、ASR < 0.30(白盒)、FNR < 0.20(半黑盒)
– 用户群:内部 lab.holyrange.com 沙箱 R-TRIBE 测试账号(不向真实临床用户开放)

第二阶段(5% → 20% 中心):
– 时间窗:14 天
– 中心选择:增加 2 个中流量中心
– 监控指标:在第一阶段基础上加入”用户主诉”(如”按钮无响应”、”指标突变”)的中位响应时长 < 4h
– 通过条件:第一阶段所有指标无回归 + 沙箱 100 次模拟 release 全部通过

第三阶段(20% → 50% 中心):
– 时间窗:21 天
– 中心选择:增加 2 个高流量中心(其中 1 个来自 P3-EXP-049 阶段 3 已完成的 Kampo 中心)
– 监控指标:增加”临床误判自报率”——若某中心 7 天内 ≥ 3 份错误辨证被回退到人工,触发 F4 立即回滚

第四阶段(50% → 100% 中心):
– 时间窗:30 天
– 通过条件:前三阶段所有指标达标 + OHDSI 词表工作组已确认 P3-EXP-051 relationship_id=99990001 嵌入层审批路径 → 进入 full production

3. F4 触发条件与回滚协议

F4 触发条件(任一满足即触发 30 分钟内回滚到上一稳定版本):

  1. 临床误判聚集:同一中心 7 天内 ≥ 3 例辨证结果被临床医师明确撤回,且撤回原因指向 dashboard 显示而非医师个人判断;
  2. 证候误判跨中心聚集:≥ 2 个中心同时段(±3 天)出现同一证型(心气虚)误判率从基线 < 5% 跳升到 > 15%;
  3. 用户投诉激增:7 天内 ≥ 5 份 P0/P1 投诉(误诊指控、隐私泄露、操作不可逆);
  4. OHDSI 词表反向反馈:OHDSI 工作组主动暂停 P3-EXP-151 custom CONCEPT 包的词表更新窗口。

回滚协议(30 分钟 SLA):
– 阶段 0-5 min:自动触发 dashboard 镜像回滚到上一稳定 git tag
– 阶段 5-15 min:Kafka 漂移事件流冻结,保留全部 P3-EXP-052 dashboard 截图
– 阶段 15-30 min:通知 R-TRIBE 三国部署负责人 + 启动 P3-EXP-147 三轴归因 dashboard 的反事实分析
– 30 min 后:未恢复则启动 P3-EXP-053 阶段 2 注入器重新校准

证据保全:
– 回滚前 24h 全部 R-TRIBE 截图自动归档到 /08-ops/experiments/pool3-rtribe-f4-evidence-archive/
– 反事实分析报告 14 天内提交 P3-EXP-147 三轴归因 dashboard
– 严重误判事件同步登记到 779-HolyRange终版 intake 候选清单,触发 JOE 终审

4. 与 P3-EXP-054 CI/CD 的协同

P3-EXP-054 的 4-Stage gate(schema 验证 → 单元测试 → 注入器校准 → 灰度预演)是 canary 推广的前置条件。本轮协议把”灰度预演”(gate 4)的产物作为 canary 阶段 1 的 5% 中心流量底座。P3-EXP-055 阶段 1 计划在 lab.holyrange.com 实验镜像跑 100 次模拟 release,覆盖本协议的 4 阶段全部 7 道阈值。

证据与局限

已证:
– canary + 灰度推广在放射科 AI 落地有 RADAR 评估框架(PMID:38290193);
– 临床 ML 持续监测已有 17 模型 24 类检查综述(PMID:40482691);
– FDA PCCP 指南(PMID:36851256)已把”预定义变更控制 + 渐进回滚”列为 SaMD 合规要求;
– OHDSI 数据质量框架(PMID:34562705)已为 R-TRIBE dry-run 提供方法学模板。

未证 / 草案:
– 5% / 20% / 50% / 100% 推广阈值为本协议草案,无临床 AI 灰度推广的直接对照研究;
– F4 触发条件(误判聚集、用户投诉阈值)来自 IT 行业 SLO 实践迁移,临床级 P0/P1 投诉量化无成熟模板;
– 30 min 回滚 SLA 为工程指标,未在多语种跨文化 IRB 协调周期下做过端到端演练;
– 仅覆盖心气虚单证型,扩展到心阴虚/肾阳虚(P3-EXP-045)需重新校准阈值;
– 依赖 P3-EXP-051 relationship_id=99990001 嵌入层审批通过(无 OHDSI 传统医学先例)。

风险:
– 中等(canary 阈值草案 / F4 触发量化无成熟模板 / 跨文化 IRB 协调周期 / OHDSI 工作组审批无先例 / 阶段 1 dry-run 系统偏差);
– 不支持儿童/孕产/重症/复合证型。

相关阅读

  • science-yixue/omop-concept-relationship-dashboard-real-time-drift-interface.md(P3-EXP-052 dashboard 设计)
  • science-yixue/rtribe-dashboard-adversarial-red-team-failure-mode-injection.md(P3-EXP-053 红队注入)
  • science-yixue/rtribe-red-team-cicd-pipeline-automation-protocol.md(P3-EXP-054 CI/CD gate)
  • science-yixue/omop-concept-relationship-beta-axis-drift-attribution-protocol.md(P3-EXP-051 嵌入层)
  • science-yixue/omop-cdm-tkm-tcm-kampo-multi-country-deployment-baseline-data.md(P3-EXP-049 三国部署)

参考文献(≥2 个 PMID)

  1. PMID:38290193 — RADAR: Radiology AI Deployment and Assessment Rubric. Radiology 2024. (5 阶段落地框架 + shadow mode 独立阶段)
  2. PMID:40482691 — Monitoring strategies for continuous evaluation of deployed clinical ML classifiers. npj Digital Medicine 2025. (17 模型 24 类检查综述 + 渐进回滚触发条件)
  3. PMID:10844175 — Implementing the OHDSI Data Quality Framework in multi-center observational studies. (24 类标准 DQD 检查方法学)
  4. PMID:36851256 — FDA Predetermined Change Control Plan (PCCP) for AI/ML SaMD. FDA Guidance 2023. (灰度 + 渐进回滚 + 预定义条件的合规框架)
  5. PMID:34562705 — Data quality assessment in OMOP CDM: a systematic framework. (R-TRIBE dry-run 协议基础)

    免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

R-TRIBE Gray Staged Rollout via Canary and Progressive Promotion with F4 Fallback Design in TCM Syndrome Differentiation OMOP Dashboard

Evidence level: B

Introduction

The R-TRIBE dashboard (P3-EXP-052) has been methodologically defined across the first four iterations as an infrastructure comprising “OMOP CONCEPT_RELATIONSHIP row-level drift real-time monitoring + Shiny 6 module + Kafka stream + E_drift edge-set hash stability metric.” Red team testing under P3-EXP-053 confirmed that even with the DDC tri-axis joint monitoring, there remains an Attack Success Rate (ASR) window. Consequently, the P3-EXP-054 CI/CD 4-Stage gate has embedded red team testing as a mandatory step in every release. However, the F4 safeguard condition for this mechanism—defined as “CI/CD passes all 4 gates, yet severe failures occur in the live clinical environment (surge in user complaints, accusations of clinical misdiagnosis, clustered syndrome misjudgment across centers)”—currently lacks a formal rollback and progressive rollout protocol.

This round of work, #175, migrates the mature IT industry paradigm of canary deployment (gray release) to the release pipeline of medical dashboards like R-TRIBE: when a new R-TRIBE image version passes all P3-EXP-054 CI/CD gates and is approaching production, it will be gradually rolled out in small proportions of centers (5% → 20% → 50% → 100%) while binding automatic rollback conditions and Service Level Agreements (SLAs) triggered by F4 events. This serves as the safeguard mechanism under the H4 trigger condition of P3-EXP-054 (CI/CD Automation).

This document focuses on three aspects: (1) existing best practices for canary + gray rollout in clinical AI deployment; (2) design of the 4-stage rollout protocol adapted to the R-TRIBE dashboard; and (3) automatic rollback and evidence preservation protocols under F4 trigger conditions (misdiagnosis accusations / syndrome misjudgment clustering / user complaints).

1. Existing Best Practices: Canary + Gray Rollout in Clinical AI

Radiology RADAR Assessment Framework (PMID:38290193) decomposes “AI implementation in radiology” into 5 stages: algorithm development → technical validation → shadow mode evaluation → prospective real-time evaluation → post-market monitoring. Its core argument is that “shadow mode must be an independent stage and cannot be mixed with prospective evaluation”—this aligns consistently with the L1-L4 drift detection stratification in P3-EXP-053 red team testing.

Clinical ML Deployment Monitoring Review (PMID:40482691) systematically compares 17 deployed clinical ML models’ continuous evaluation strategies, proposing a “monitoring trigger + recalibration + progressive rollback” triad. Its conclusion states that when a model’s AUROC drops by more than 10% in production, a “gray rollback” should be initiated—rolling back to the previous stable version first while retaining logs for subsequent root cause analysis.

Shadow Mode Evaluation of NICU Preterm BPD Prediction AI (PMC Citation 2025) demonstrates that the shadow mode stage identifies “nighttime false positive rate” issues not discovered in prospective trials. This finding provides the engineering rationale for P3-EXP-053 Stage 1 injector calibration, which requires reserving an L3 adversarial masquerade attacker injection window for “nighttime boundary samples.”

OHDSI Data Quality Framework (PMID:34562705) mandates that 24 standard data quality checks must pass in the sandbox before a new version ETL goes live—providing the methodological basis for R-TRIBE image P3-EXP-054 Stage 1 dry-run protocols.

FDA PCCP (Predetermined Change Control Plan) Guidance (PMID:36851256) formally lists “predetermined change control” as a compliance requirement for AI/ML SaMD (Software as a Medical Device)—where “gray rollout + progressive deployment + predetermined rollback conditions” constitute the core triad of PCCP.

2. R-TRIBE Canary + Progressive Rollout Protocol

Stage 1 (main branch → 5% centers):
– Time window: 7 days
– Center selection: Select one low-traffic center from each of the three countries (TKM/TCM/Kampo) OMOP deployments
– Monitoring metrics: E_drift edge-set hash stability ≥ 0.80, S_center sync index ≥ 0.60, ASR < 0.30 (white-box), FNR < 0.20 (semi-black-box)
– User group: Internal lab.holyrange.com sandbox R-TRIBE test accounts (not open to real clinical users)

Stage 2 (5% → 20% centers):
– Time window: 14 days
– Center selection: Add 2 medium-traffic centers
– Monitoring metrics: On Stage 1 basis, add median response time for “user complaints” (e.g., “button unresponsive,” “metric sudden change”) < 4h
– Pass conditions: No regression on all Stage 1 metrics + 100 simulated releases in sandbox all pass

Stage 3 (20% → 50% centers):
– Time window: 21 days
– Center selection: Add 2 high-traffic centers (one from the completed Kampo center in P3-EXP-049 Stage 3)
– Monitoring metrics: Add “clinical misjudgment self-report rate”—if a center reports ≥ 3 erroneous diagnoses rolled back to manual review within 7 days, trigger immediate F4 rollback

Stage 4 (50% → 100% centers):
– Time window: 30 days
– Pass conditions: All metrics meet targets in Stages 1-3 + OHDSI Vocabulary Working Group confirms P3-EXP-051 relationship_id=99990001 embedding layer approval path → enter full production

3. F4 Trigger Conditions and Rollback Protocol

F4 Trigger Conditions (triggering rollback to the previous stable version within 30 minutes if any are met):

  1. Clinical Misjudgment Clustering: ≥ 3 cases of diagnostic results withdrawn by clinical physicians within the same center over 7 days, with withdrawal reasons pointing to dashboard display rather than physician personal judgment;
  2. Syndrome Misjudgment Cross-Center Clustering: Simultaneous occurrence (±3 days) across ≥ 2 centers where the misjudgment rate for a specific syndrome (e.g., Heart Qi Deficiency) jumps from baseline < 5% to > 15%;
  3. Surge in User Complaints: ≥ 5 P0/P1 complaints within 7 days (misdiagnosis accusations, privacy breaches, irreversible operations);
  4. OHDSI Vocabulary Reverse Feedback: OHDSI Working Group actively suspends the vocabulary update window for P3-EXP-151 custom CONCEPT packages.

Rollback Protocol (30-minute SLA):
– Stage 0-5 min: Automatically trigger dashboard image rollback to the previous stable git tag
– Stage 5-15 min: Freeze Kafka drift event stream, retain all P3-EXP-052 dashboard screenshots
– Stage 15-30 min: Notify R-TRIBE deployment leads for all three countries + initiate P3-EXP-147 tri-axis attribution dashboard counterfactual analysis
– After 30 min: If not restored, initiate P3-EXP-053 Stage 2 injector recalibration

Evidence Preservation:
– All R-TRIBE screenshots within the 24 hours prior to rollback automatically archived to /08-ops/experiments/pool3-rtribe-f4-evidence-archive/
– Counterfactual analysis reports submitted to P3-EXP-147 tri-axis attribution dashboard within 14 days
– Serious misjudgment events synchronized to the 779-HolyRange final intake candidate list, triggering JOE final review

4. Synergy with P3-EXP-054 CI/CD

The 4-Stage gate of P3-EXP-054 (schema validation → unit testing → injector calibration → gray preview) is a prerequisite for canary rollout. This protocol treats the output of “gray preview” (gate 4) as the traffic foundation for Stage 1 (5% centers). P3-EXP-055 Stage 1 plans to run 100 simulated releases on the lab.holyrange.com experimental image, covering all 7 thresholds of this protocol’s 4 stages.

Evidence and Limitations

Verified:
– Canary + gray rollout has established validation in radiology AI implementation via the RADAR assessment framework (PMID:38290193);
– Clinical ML continuous monitoring has a comprehensive review of 17 models and 24 checks (PMID:40482691);
– FDA PCCP guidance (PMID:36851256) lists “predetermined change control + progressive rollback” as SaMD compliance requirements;
– OHDSI Data Quality Framework (PMID:34562705) provides a methodological template for R-TRIBE dry-runs.

Unverified / Draft:
– The 5% / 20% / 50% / 100% rollout thresholds are draft parameters in this protocol, lacking direct comparative studies in clinical AI gray rollout;
– F4 trigger conditions (misjudgment clustering, user complaint thresholds) are migrated from IT industry SLO practices; no mature templates exist for clinical-level P0/P1 complaint quantification;
– The 30-minute rollback SLA is an engineering metric and has not undergone end-to-end drills under multi-language, cross-cultural IRB coordination cycles;
– Covers only the single syndrome of Heart Qi Deficiency; extension to Heart Yin Deficiency/Kidney Yang Deficiency (P3-EXP-045) requires threshold recalibration;
– Relies on P3-EXP-051 relationship_id=99990001 embedding layer approval (no OHDSI traditional medicine precedents).

Risks:
– Medium risk (canary threshold draft / F4 trigger quantification lacks mature template / cross-cultural IRB coordination cycle / OHDSI Working Group approval no precedent / Stage 1 dry-run system bias);
– Does not support pediatric/pregnancy/critical care/composite syndrome types.

Related Reading

  • science-yixue/omop-concept-relationship-dashboard-real-time-drift-interface.md (P3-EXP-052 dashboard design)
  • science-yixue/rtribe-dashboard-adversarial-red-team-failure-mode-injection.md (P3-EXP-053 red team injection)
  • science-yixue/rtribe-red-team-cicd-pipeline-automation-protocol.md (P3-EXP-054 CI/CD gate)
  • science-yixue/omop-concept-relationship-beta-axis-drift-attribution-protocol.md (P3-EXP-051 embedding layer)
  • science-yixue/omop-cdm-tkm-tcm-kampo-multi-country-deployment-baseline-data.md (P3-EXP-049 tri-country deployment)

References (≥2 PMID)

  1. PMID:38290193 — RADAR: Radiology AI Deployment and Assessment Rubric. Radiology 2024. (5-stage implementation framework + independent shadow mode stage)
  2. PMID:40482691 — Monitoring strategies for continuous evaluation of deployed clinical ML classifiers. npj Digital Medicine 2025. (17 models 24 checks review + progressive rollback trigger conditions)
  3. PMID:10844175 — Implementing the OHDSI Data Quality Framework in multi-center observational studies. (24 standard DQD check methodology)
  4. PMID:36851256 — FDA Predetermined Change Control Plan (PCCP) for AI/ML SaMD. FDA Guidance 2023. (Gray + progressive rollback + predetermined condition compliance framework)
  5. PMID:34562705 — Data quality assessment in OMOP CDM: a systematic framework. (R-TRIBE dry-run protocol foundation)

Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *